BACKGROUND: No study outside the UK has examined the diagnostic stability of psychotic disorders in a population-based sample. AIMS: To determine diagnostic stability in a Dutch population-based psychosis incidence cohort, to examine the frequencies of diagnostic shifts to and from schizophrenic disorders and to report the revised relative risks of schizophrenic disorders for immigrants. METHOD: A 30-month follow-up study assessed the cohort (n=181) by means of face-to-face diagnostic interviews. RESULTS: Diagnostic stability of schizophrenic disorders was high (91%), but lower for other psychotic disorders. At follow-up, the initial diagnosis was adjusted to schizophrenic disorder more often than that the reverse occurred. Almost half (49%) of the patients who were not initially diagnosed as having a schizophrenic disorder received this diagnosis at follow-up. The relative risks for most immigrant groups were stable. CONCLUSIONS: Schizophrenic disorders are underdiagnosed, rather than overdiagnosed, at first presentation.
BACKGROUND: No study outside the UK has examined the diagnostic stability of psychotic disorders in a population-based sample. AIMS: To determine diagnostic stability in a Dutch population-based psychosis incidence cohort, to examine the frequencies of diagnostic shifts to and from schizophrenic disorders and to report the revised relative risks of schizophrenic disorders for immigrants. METHOD: A 30-month follow-up study assessed the cohort (n=181) by means of face-to-face diagnostic interviews. RESULTS: Diagnostic stability of schizophrenic disorders was high (91%), but lower for other psychotic disorders. At follow-up, the initial diagnosis was adjusted to schizophrenic disorder more often than that the reverse occurred. Almost half (49%) of the patients who were not initially diagnosed as having a schizophrenic disorder received this diagnosis at follow-up. The relative risks for most immigrant groups were stable. CONCLUSIONS:Schizophrenic disorders are underdiagnosed, rather than overdiagnosed, at first presentation.
Authors: Paola Salvatore; Ross J Baldessarini; Mauricio Tohen; Hari-Mandir K Khalsa; Jesus Perez Sanchez-Toledo; Carlos A Zarate; Eduard Vieta; Carlo Maggini Journal: J Clin Psychiatry Date: 2010-07-13 Impact factor: 4.384
Authors: David M Ndetei; Lincoln I Khasakhala; Francisca A Ongecha; Victoria Mutiso; Donald A Kokonya Journal: Afr Health Sci Date: 2007-12 Impact factor: 0.927
Authors: Warrick J Brewer; Ashleigh Lin; Paul J Moberg; Gregory Smutzer; Barnaby Nelson; Alison R Yung; Christos Pantelis; Patrick D McGorry; Bruce I Turetsky; Stephen J Wood Journal: Psychiatry Res Date: 2012-04-14 Impact factor: 3.222
Authors: Kelly K Anderson; Rebecca Fuhrer; Willy Wynant; Michal Abrahamowicz; David L Buckeridge; Ashok Malla Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2013-02-21 Impact factor: 4.328
Authors: Scott W Woods; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan Journal: Schizophr Bull Date: 2009-04-21 Impact factor: 9.306
Authors: Paola Salvatore; Ross J Baldessarini; Mauricio Tohen; Hari-Mandir K Khalsa; Jesus Perez Sanchez-Toledo; Carlos A Zarate; Eduard Vieta; Carlo Maggini Journal: J Clin Psychiatry Date: 2008-12-30 Impact factor: 4.384